Growth Hormone Receptor Antagonist Applications in Water Quality Monitoring, Agriculture, and Biomedical Diagnostics

The inventive concept leverages the core technology of growth hormone receptor antagonists to develop novel applications in water quality monitoring, agriculture, and biomedical diagnostics, providing innovative solutions for various industries.

The original patent disclosed a composition for treating cancer and other diseases using modified human growth hormone receptor antagonists. However, the patent's scope was limited to pharmaceutical applications. This inventive concept addresses the need for applying the core technology to entirely different industries, such as environmental monitoring, agriculture, and biomedical diagnostics, where growth hormone receptor antagonists can provide unique benefits.

The inventive concept comprises four main applications: (1) a system for monitoring water quality by detecting growth hormone receptor expression in aquatic organisms, enabling early warnings for waterborne diseases; (2) a method for predicting crop yield by applying modified human growth hormone receptor antagonists to crops, enhancing plant growth and development; (3) a device for diagnosing neurodegenerative disorders by detecting growth hormone receptor expression in neural tissue, facilitating early disease detection; and (4) a system for optimizing livestock feed by detecting growth hormone receptor expression in livestock, ensuring optimal feed composition.

The inventive concept's novelty lies in the unexpected application of growth hormone receptor antagonists to non-pharmaceutical fields, where their unique properties provide innovative solutions. The inventive step resides in the recognition of the potential for growth hormone receptor antagonists to address specific problems in water quality monitoring, agriculture, and biomedical diagnostics.

Alternative embodiments may include the use of different types of sensors or probes for detecting growth hormone receptor expression, or the development of novel formulations for the modified human growth hormone receptor antagonists. Variations of the inventive concept may also include the application of growth hormone receptor antagonists to other industries, such as veterinary medicine or biotechnology.

The inventive concept has significant commercial potential in the environmental monitoring, agriculture, and biomedical diagnostics industries, with potential markets including water treatment facilities, agricultural companies, and biomedical research institutions.